Pharmaresearch Stocks Receive Mixed Target Adjustments on Rejuran Expansion
Pharmaresearch received mixed stock price target adjustments from securities firms on May 16 as the company expands its Rejuran skincare brand into cosmetics and overseas markets. Samsung Securities raised its target from 400,000 KRW to 420,000 KRW, and Kiwoom Securities increased its target from 44
PharmaResearch3.36%
CryptoFrontier·07-18 08:39
